sever
acut
respiratori
syndrom
sar
caus
novel
human
coronaviru
cov
establish
fatal
human
respiratori
diseas
sarscov
transmit
virusladen
droplet
like
also
via
either
aerosol
fecalor
rout
lung
main
patholog
target
exact
mechan
sar
pathogenesi
remain
unknown
patholog
examin
lung
biopsi
autopsi
specimen
sar
patient
reveal
diffus
alveolar
damag
vari
stage
sever
extens
disrupt
epitheli
cell
accumul
reactiv
macrophag
accompani
presenc
hemophagocyt
syndrom
patient
succumb
diseas
strikingli
pulmonari
manifest
sar
patient
usual
occur
clearanc
viremia
often
absenc
opportunist
infect
taken
togeth
observ
led
hypothesi
sar
pathogenesi
might
stem
illregul
often
excess
inflammatori
respons
within
lung
likelihood
sar
immunemedi
diseas
support
report
within
circul
lung
patient
affect
sar
highli
elev
express
variou
inflammatori
mediat
includ
interleukin
il
protein
ip
chemoattract
protein
mcp
activ
normal
express
secret
rant
induc
interferongamma
mig
exacerb
cytokin
respons
subsequ
demonstr
experiment
infect
mice
especi
transgen
express
human
angiotensinconvert
enzym
viral
receptor
contrast
promin
elev
cytokin
respons
rather
challeng
detect
signific
respons
type
ifn
individu
mice
infect
sarscov
failur
sarscov
induc
readili
detect
type
ifn
respons
subsequ
demonstr
mani
vitro
studi
use
variou
cell
type
nonpulmonari
origin
includ
african
green
monkey
kidney
cell
vero
cell
human
peripher
blood
mononuclear
cell
pbmc
intestin
epitheli
cell
hepatoma
cell
embryon
kidney
hek
cell
type
ifn
shown
effect
sarscov
infect
vitro
vivo
defici
respons
type
ifn
infect
host
led
hypothesi
sarscov
evolv
strategi
evad
potent
ifnrel
innat
antivir
respons
inde
subsequ
demonstr
sarscovencod
nucleocapsid
n
recent
membran
protein
could
function
antagonist
host
antivir
defens
interrupt
axi
ifnrel
antivir
pathway
promot
degrad
cellular
rna
inhibit
ifn
product
interf
format
complex
respect
furthermor
suggest
sarscov
member
group
cov
mous
hepat
viru
mhv
could
effect
evad
ifnrel
antivir
respons
activ
avoid
recognit
replic
rna
host
innat
sens
mechan
human
airway
epithelium
like
one
initi
site
sarscov
infect
addit
function
physic
mechan
barrier
separ
elimin
inhal
harm
infecti
noninfecti
materi
lung
epitheli
cell
directli
respond
respiratori
infect
secret
variou
molecul
serv
initi
amplifi
andor
sustain
host
inflammatori
respons
regard
recent
shown
andor
releas
sarscovinfect
human
bronchoepitheli
cell
could
exacerb
host
innat
inflammatori
respons
part
modul
intrins
function
macrophag
dendrit
cell
dc
thu
thorough
understand
human
lung
epitheli
cell
respond
sarscov
infect
crucial
advanc
knowledg
sar
pathogenesi
also
identifi
novel
highli
valuabl
cellular
target
innov
intervent
sar
scarciti
importantli
highli
heterogen
natur
normal
human
bronchial
epitheli
nhbe
cell
regard
express
thu
permiss
sarscov
infect
tseng
ck
et
al
unpublish
observ
greatli
limit
use
explor
genomewid
respons
viral
infect
although
human
bronchial
epitheli
cell
like
nhbe
cell
heterogen
avail
wellcharacter
interact
sarscov
make
better
choic
nhbe
cell
underscor
innat
antivir
signal
pathway
induc
sarscov
patholog
relev
cell
howev
fact
cell
express
differ
intens
compromis
use
underscor
host
innat
antivir
signal
pathway
explicitli
trigger
sarscov
overcom
establish
clonal
deriv
cell
standard
limit
dilut
base
intens
homogen
importantli
stabl
express
variou
passag
chose
clone
explor
innat
epitheli
signal
pathway
elicit
sarscov
microarraybas
function
genom
analyz
global
gene
respons
cell
time
respons
sarscov
infect
attempt
clarifi
characterist
innat
antivir
respons
trigger
sarscov
also
simultan
analyz
gene
express
profil
cell
infect
dhori
viru
dhov
orthomyxoviru
known
product
infect
cell
lead
profound
product
ifn
inflammatori
cytokin
hill
et
al
manuscript
prepar
contrari
prevail
vitro
studi
emphas
lack
readili
detect
ifn
respons
find
cell
mount
activ
respons
howev
especi
respons
delay
rel
andor
mediat
proinflammatori
respons
transcript
translat
level
abil
cell
activ
ifnrel
signal
pathway
respons
sarscov
infect
verifi
subsequ
express
mani
interferonstimul
gene
isg
sarscov
infect
capabl
activ
aforement
gene
relat
innat
antivir
respons
magnitud
express
notic
high
induc
dhov
also
notic
translat
machineri
mrna
transcript
cell
effici
especi
interestingli
sarscovassoci
ineffici
translat
gene
encod
observ
dhovinfect
cell
final
found
first
time
andor
type
iii
ifn
exert
protect
role
either
alon
combin
otherwis
ineffect
sarscov
dosedepend
manner
taken
togeth
data
offer
compel
evid
human
bronchial
epitheli
cell
capabl
promot
activ
delay
ifnrel
antivir
respons
thu
provid
new
insight
sar
pathogenesi
employ
standard
limit
dilut
techniqu
establish
clonal
deriv
cell
describ
materi
method
base
express
permiss
product
sarscov
infect
total
clone
establish
exhibit
array
vari
intens
express
permiss
sarscov
rang
intermediatetolow
level
wherea
remain
eight
clone
reveal
increas
express
suscept
sarscov
infect
compar
parent
cell
data
shown
among
clone
highli
permiss
sarscov
chose
cell
clone
detail
character
regard
stabil
express
differ
passag
suscept
product
sarscov
infect
shown
figur
result
ihc
stain
reveal
express
cell
passag
much
intens
parent
cell
enhanc
express
cell
rel
cell
confirm
western
blot
analysi
figur
importantli
trend
intens
express
cell
appear
stabl
cell
deriv
two
differ
passag
ie
exhibit
littl
differ
express
protein
parent
cell
wich
origin
human
pulmonari
adenocarcinoma
well
character
noncili
human
bronchial
epitheli
cell
express
mani
marker
serou
gland
cell
format
tight
junction
tj
complex
morpholog
cell
grown
membran
insert
subsequ
examin
tem
shown
figur
cell
like
parent
cell
appear
morpholog
resembl
noncili
pseudostratifi
columnar
epitheli
cell
express
microvilli
apic
surfac
format
tj
complex
permiss
sarscov
infect
cell
passag
cell
investig
time
result
depict
figur
becam
clear
infect
cell
moi
either
passag
equal
capabl
promot
strikingli
intens
product
progeni
virus
parent
cell
kinet
viral
replic
cell
passag
also
evalu
infecti
center
assay
well
standard
ihc
estim
percentag
infect
cell
examin
morpholog
chang
infect
cell
respect
shown
figur
infect
cell
gradual
increas
hr
ie
hr
ie
reach
hr
similarli
express
sarscov
n
protein
reveal
ihc
readili
detect
infect
cell
hr
significantli
increas
hr
reach
maximum
pi
accompani
appear
round
enlarg
cell
cpe
figur
becam
detach
cultur
vessel
data
shown
taken
togeth
result
indic
cell
homogen
regard
stabil
express
permiss
sarscov
infect
therebi
provid
sensit
patholog
relev
vitro
model
character
host
innat
antivir
signal
pathway
explicitli
trigger
sarscov
employ
cdna
microarray
analyz
pattern
global
gene
express
cell
respons
sarscov
first
step
explor
like
antivir
signal
pathway
ascrib
uniqu
properti
sarscovinduc
innat
respons
would
ideal
compar
elicit
anoth
strain
human
coronaviru
hcov
eg
unfortun
neither
could
product
infect
cell
data
shown
make
comparison
unlik
dhov
propos
orthomyxovir
surrog
highli
pathogen
avian
influenza
viru
product
infect
cell
result
highli
intens
secret
type
ifn
innat
inflammatori
mediat
hill
et
al
unpublish
data
compar
global
gene
express
cell
respons
sarscov
versu
dhov
microarraybas
analysi
tempor
gene
express
cell
respons
sarscov
dhov
infect
perform
simultan
within
experiment
set
result
relev
dhov
infect
unless
indic
otherwis
subject
separ
manuscript
hill
et
al
prepar
specif
particularli
interest
compar
viral
induc
gene
either
encod
relev
express
ifn
inflammatori
cytokin
sar
pathogenesi
propos
stem
combin
bare
detect
ifn
exacerb
cytokin
respons
patient
sever
affect
sarscov
infect
tempor
express
host
gene
determin
compar
rel
abund
specif
mrna
mock
versu
sarscovinfect
versu
dhovinfect
cell
moi
harvest
hr
pi
microarraybas
studi
global
gene
respons
perform
triplic
time
point
yield
array
analysi
gene
whose
express
significantli
modul
ie
p
compar
mockinfect
control
replic
n
analyz
time
point
select
investig
kinet
viral
replic
also
determin
time
point
correl
level
viral
infect
extent
host
gene
respons
construct
venn
diagram
base
result
stringent
microarray
analysi
roughli
reflect
tempor
chang
gene
express
sarscovinfect
cell
shown
figur
identifi
total
gene
whose
express
significantli
downregul
infect
cell
time
ie
hr
respect
capac
sarscov
modul
gene
express
infect
cell
potent
dhov
whose
infect
result
gene
significantli
upregul
downregul
respect
data
shown
among
total
sarscovregul
gene
ie
downregul
gene
upregul
gene
detect
earliest
time
point
ie
hr
express
gene
continu
increas
time
reach
highest
magnitud
hr
function
signal
pathway
analysi
earli
viral
induc
persist
host
gene
n
reveal
except
gene
whose
function
larg
associ
regul
innat
inflammatori
respons
remain
seven
gene
ie
cjun
cfo
function
relat
transcript
factor
tf
act
either
suppressor
phosphatas
kinas
tabl
besid
earli
activ
gene
total
gene
whose
express
significantli
alter
ie
either
downregul
pi
respect
tf
regul
gene
transcript
play
critic
role
variou
biolog
process
includ
host
innat
respons
invad
pathogen
major
tf
also
known
regul
express
multipl
often
overlap
gene
infer
activ
key
tf
earli
phase
sarscov
infect
ie
hr
tabl
prompt
us
analyz
tempor
activ
tf
use
transcript
factor
databas
known
transfac
among
tf
deduc
activ
hr
activ
stat
persist
throughout
entir
cours
infect
ie
hr
therebi
suggest
close
role
regul
epitheli
respons
sarscov
infect
tabl
figur
signific
activ
tf
belong
either
famili
eg
crebatf
famili
eg
creb
crebatf
also
detect
hr
wherea
activ
molecul
critic
involv
induct
type
ifn
could
observ
hr
pi
figur
identifi
function
pattern
might
allow
us
better
understand
biolog
relev
tempor
regul
gene
infect
cell
significantli
downregul
gene
subject
gene
ontogeni
go
base
annot
function
analysi
applic
name
enrich
go
term
gene
analyz
depict
figur
accord
molecular
function
biolog
process
respect
function
enrich
go
term
identifi
thu
far
gene
upregul
hr
pi
appear
close
involv
either
genom
transcript
ie
tf
sequencespecif
dna
andor
doublestrand
rna
bind
oligopeptid
transport
protein
dimer
inflammatori
respons
figur
initi
activ
gene
encod
inflammatori
cytokin
andor
chemokin
detect
first
hr
express
enhanc
hr
contrast
activ
peptidyldipeptidas
ie
angiotensin
convert
enzym
ace
ie
sarscov
receptor
infect
cell
significantli
reduc
hr
figur
protect
function
acut
lung
injuri
reduc
express
consequ
sarscov
infect
might
worsen
pathogenesi
result
sarscov
infect
express
gene
function
relat
oxidoreductas
also
reduc
hr
subsequ
impact
host
respons
andor
sar
pathogenesi
remain
current
unknown
significantli
modul
gene
analyz
accord
biolog
process
could
identifi
enrich
go
term
gene
whose
express
downregul
time
contrast
abl
assign
enrich
goannot
term
describ
biolog
theme
gene
whose
express
upregul
infect
cell
figur
among
annot
biolog
entiti
express
gene
directli
involv
process
cell
differenti
cell
cycl
progress
celltocel
signal
significantli
upregul
earli
hr
remain
highli
elev
hr
pi
wherea
gene
highli
relev
host
immun
respons
induc
hr
pi
interestingli
highli
elev
express
gene
goannot
biolog
function
respons
viru
immun
respons
particularli
promin
support
extrem
low
p
valu
thought
sar
pathogenesi
like
stem
part
illregul
often
excess
innat
inflammatori
respons
respiratori
sarscov
infect
relevantli
measur
possibl
impact
infect
lung
epitheli
cell
might
tempor
host
immun
respons
vivo
gener
heat
map
two
elev
gene
set
infect
cell
repres
immun
responsesrespons
viru
n
cytokineschemokin
n
respect
shown
figur
gene
encod
appear
among
first
batch
inflammatori
gene
activ
sarscov
hr
induct
earli
inflammatori
gene
continu
increas
hr
accompani
upregul
host
gene
relev
innat
inflammatori
andor
antivir
process
includ
mani
interferonstimul
gene
isg
mx
oass
rigi
stat
etc
determin
whether
transcript
activ
gene
code
variou
inflammatori
mediat
especi
could
extend
translat
level
gamma
irradi
supernat
mockinfect
sarscovinfect
cultur
moi
indic
time
point
pi
subject
bioplex
elisa
andor
vsvverobas
plaquereduct
assay
assess
content
cytokin
chemokin
ifn
among
cytokin
chemokin
could
simultan
measur
use
human
group
ii
bioplex
abl
detect
significantli
elev
express
fibroblast
growth
factor
fgf
basic
protein
ip
plateletderiv
growth
factor
pdgf
bb
either
hr
pi
figur
could
also
detect
increas
express
protein
hr
elisa
induct
mani
host
gene
could
confirm
transcript
translat
level
enhanc
express
gene
code
fgf
basic
pdgf
bb
two
molecul
frequent
implic
particip
process
variou
patholog
condit
could
detect
translat
transcript
level
andor
hr
pi
contrari
elev
express
inflammatori
mediat
product
antagonist
infect
cell
significantli
reduc
earli
hr
pi
sustain
hr
pi
discord
mrna
protein
express
gene
encod
fgf
basic
pdgf
bb
sarscovinfect
cell
prompt
us
evalu
correl
mrna
correspond
protein
express
among
cohort
viral
activ
gene
includ
select
hr
hr
pi
two
conspicu
time
point
detect
upregul
mrna
protein
level
respect
analysi
calcul
foldincreas
either
mrna
protein
individu
gene
elicit
infect
cell
mockinfect
n
indic
time
point
simpli
divid
raw
valu
mrna
protein
individu
gene
express
infect
cell
detect
mockinfect
one
result
valu
subject
spearman
correl
coeffici
analysi
establish
interrelationship
mrna
protein
express
target
gene
shown
figur
exist
strong
posit
correl
transcript
translat
express
gene
encod
respect
p
contrast
level
mrna
correspond
protein
correl
poorli
gene
level
mrna
transcript
readili
detect
protein
determin
whether
poor
effici
protein
express
particularli
cell
uniqu
consequ
sarscov
infect
perform
parallel
analysi
mrna
protein
express
profil
gene
whose
express
significantli
activ
cell
upon
infect
sarscov
dhov
compar
express
level
mrna
protein
target
gene
briefli
rel
mrna
protein
express
efficaci
gene
elicit
differenti
infect
cell
calcul
divid
amount
mrna
protein
detect
sarscovinfect
cultur
express
dhovinfect
one
harvest
time
point
pi
shown
figur
drew
dot
line
repres
onetoon
ratio
gene
mrna
protein
express
thu
gene
plot
dot
line
would
repres
whose
protein
express
mrna
transcript
effici
express
dhovinfect
cell
wherea
gene
plot
underneath
dot
line
repres
whose
express
readili
detect
sarscovinfect
cultur
becam
clear
sarscovinfect
cell
abl
retain
abil
express
activ
gene
especi
particularli
ineffici
posttranscript
express
mani
antivir
gene
especi
encod
compar
dhovinfect
cell
taken
togeth
result
lead
us
suggest
sarscov
might
evolv
strategi
like
via
preferenti
target
ifnrel
antivir
gene
posttranscript
level
success
establish
infect
immunecompet
cell
type
ifn
rapidli
produc
infect
host
serv
first
line
defens
viral
infect
part
via
trigger
express
mani
isg
combat
invad
pathogen
abil
sarscov
activ
mx
oa
rigi
stat
mani
isg
without
stimul
signific
respons
especi
prompt
us
investig
whether
elicit
infect
cell
could
potenti
activ
sarscov
evalu
potenti
alon
combin
type
ifn
sarscov
infect
pretreat
cell
either
individu
combin
indic
concentr
prior
infect
sarscov
moi
concentr
ng
equival
iu
alon
signific
antivir
effect
unabl
reveal
antivir
effect
either
use
alon
concentr
high
ng
figur
howev
combin
treatment
even
concentr
low
ng
significantli
reduc
sarscov
replic
p
suggest
us
type
requir
effect
limit
replic
sarscov
figur
addit
treatment
either
type
togeth
otherwis
ineffect
lowdos
eg
iu
drastic
hamper
growth
sarscov
cell
p
find
may
impli
either
speci
could
potenti
antivir
effect
surprisingli
also
found
pretreat
cell
three
type
ifn
togeth
ie
lowdos
regimen
ie
ng
ng
diminish
antivir
effect
provid
combin
treatment
concentr
mechan
interest
observ
remain
unknown
result
show
possess
previous
unidentifi
type
ifnlik
activ
sarscov
intens
acut
inflammatori
respons
concomit
extrem
unremark
secret
hallmark
sarscov
infect
howev
molecular
mechan
attribut
highli
dysregul
innat
antivir
respons
sarscovinfect
cell
especi
patholog
relev
lung
epitheli
cell
remain
elus
report
wherea
human
bronchial
cell
secret
high
level
biolog
activ
respons
sarscov
infect
fail
mount
detect
respons
cell
highli
heterogen
regard
express
viral
receptor
strive
succeed
establish
variou
clone
cell
would
valuabl
studi
host
respons
sarscov
infect
global
host
gene
express
respons
sarscov
infect
previous
report
variou
cell
type
includ
less
permiss
human
pbmc
primari
highli
permiss
patholog
irrelev
cell
cell
even
vero
cell
addit
elucid
host
gene
express
studi
base
singl
time
point
infect
rang
hr
pi
studi
cell
except
rna
sampl
collect
hr
pi
analyz
base
stabl
intens
ace
express
thu
enhanc
permiss
product
sarscov
infect
compar
parent
cell
figur
chose
clone
cell
studi
tempor
express
airway
epitheli
gene
relat
innat
antivir
defens
sarscov
infect
use
microarraybas
function
genom
well
document
innat
antivir
signal
initi
upon
recognit
conserv
molecular
structur
share
invad
pathogen
variou
origin
known
pathogenassoci
molecular
pattern
pamp
specif
pattern
recognit
receptor
prr
molecul
express
host
cell
ultim
lead
activ
transcript
factor
primarili
induct
proinflammatori
mediat
use
vitro
system
demonstr
stat
among
earliest
tf
activ
hr
fact
activ
persist
throughout
entir
cours
infect
ie
hr
figur
strongli
argu
import
role
regul
epitheli
respons
sarscov
critic
role
statmedi
signal
pathway
activ
mani
isg
gene
code
variou
proinflammatori
mediat
well
character
although
sever
tf
belong
crebatf
famili
heterodimer
complex
ie
creb
crebatf
known
regul
transduct
mani
inflammatori
gene
subsequ
activ
hr
activ
occur
hr
pi
figur
delay
activ
rel
cell
appear
uniqu
sarscov
observ
dhovinfect
cell
data
shown
abil
rapidli
synthes
secret
type
ifn
especi
key
element
innat
antivir
respons
effect
transcript
induct
gene
requir
coordin
induct
bind
least
three
promoterspecif
tf
ie
although
activ
andor
mediat
pathway
could
contribut
gene
induct
studi
target
gene
knockout
ko
mice
clearli
indic
andor
molecul
play
indispens
distinct
role
induct
respons
viral
infect
constitut
express
mani
cell
wherea
express
highli
induc
ifn
demonstr
activ
primarili
respons
earli
limit
induct
gene
turn
bind
correspond
type
ifn
receptor
autocrin
andor
paracrin
manner
initi
posit
feedback
loop
induct
subsequ
activ
further
product
unfortun
transfac
databas
use
studi
identifi
enrich
tf
contain
data
regulatori
bind
site
prevent
us
deduc
whether
activ
induc
cell
upon
sarscov
infect
howev
elev
transcript
activ
gene
code
mani
isg
detect
hr
infect
cell
strongli
argu
activ
sarscov
cell
howev
impact
delay
activ
indispens
pathway
rel
andor
induct
potent
ifnassoci
epitheli
antivir
respons
might
signific
molecular
mechan
respons
delay
activ
infect
cell
remain
unknown
howev
report
sarscov
capabl
evad
innat
antivir
respons
encod
antagonist
molecul
target
differ
host
antivir
pathway
specif
n
protein
sarscov
counteract
host
innat
antivir
respons
specif
inhibit
activ
lead
inhibit
gene
induct
wherea
sarscovencod
protein
facilit
immun
evas
either
promot
degrad
inhibit
translat
cellular
mrna
transcript
also
report
sarscov
could
directli
interrupt
nuclear
transloc
activ
prevent
induct
ifnmedi
antivir
respons
final
abil
sarscov
protein
activ
interfer
format
complex
therebi
inhibit
activ
yet
anoth
mechan
sarscov
prevent
product
taken
togeth
sarscov
appear
preferenti
target
axi
ifnrel
signal
pathway
rather
inflammatori
responsebound
andor
pathway
circumv
host
innat
antivir
activ
howev
interfer
signal
axi
impos
sarscov
cell
appear
incomplet
evidenc
increas
express
mani
antivir
gene
isg
hr
figur
thu
like
mani
virus
sarscov
might
establish
strategi
antagon
host
antivir
respons
delay
rather
complet
block
ifnrel
signal
pathway
earli
enhanc
express
figur
potent
chemoattract
activ
cell
nk
cell
within
circul
lung
patient
affect
sar
associ
advers
outcom
sar
thu
abil
infect
cell
retain
promin
highli
correl
transcript
translat
activ
gene
other
figur
might
relev
sar
pathogenesi
contrast
highli
correl
mrnaprotein
express
observ
especi
specif
express
gene
sarscovinfect
cell
readili
detect
transcript
rather
translat
level
figur
importantli
dispar
posttranscript
effici
among
gene
test
studi
inherit
cell
cell
infect
dhov
quit
capabl
express
transcript
protein
highli
correl
manner
figur
hill
et
al
prepar
taken
togeth
result
suggest
express
especi
protein
profoundli
inhibit
sarscov
infect
impos
gener
suppress
host
posttranscript
machineri
cell
observ
consist
report
sarscov
protein
failur
effect
translat
transcript
also
report
recent
mous
fibroblast
infect
mhv
stain
interestingli
inhibit
product
protein
appear
occur
posttranscript
level
without
affect
stabil
either
mrna
transcript
synthes
protein
except
enhanc
protein
level
aforement
gene
includ
could
convincingli
detect
hr
pi
figur
howev
transcript
mani
isg
eg
mx
oass
rigi
stat
present
hr
therebi
strongli
argu
likelihood
minut
physiolog
relev
amount
andor
protein
otherwis
undetect
bioplex
elisa
andor
standard
plaqu
reduct
assay
produc
sarscovinfect
cell
earli
infect
similar
induct
express
viral
induc
express
also
reli
activ
signal
axi
despit
strike
similar
two
class
ifn
regard
pattern
activ
express
biolog
function
recent
report
viral
induc
product
much
intens
stomach
intestin
lung
compar
find
cn
spleen
furthermor
epitheli
cell
seem
preferenti
respons
latter
result
compar
cell
type
therebi
lead
suggest
exhibit
tissu
cell
specif
recent
studi
compar
role
host
innat
immun
respiratori
influenza
viru
versu
hepatotrop
thogotoviru
ifn
receptor
knockout
mice
indic
contribut
host
defens
viral
pathogen
infect
lung
liver
emphas
tissuerestrict
manner
antivir
respons
thu
use
human
bronchial
epitheli
cell
may
respons
success
identifi
highli
elev
express
gene
novel
biomark
sarscov
infect
efficaci
prophylaxi
sarscov
infect
well
establish
rel
contribut
epitheli
defens
sarscov
infect
yet
explor
show
sarscov
replic
could
drastic
inhibit
ie
use
togeth
even
low
dose
ng
per
iu
iu
either
ifn
use
alon
even
high
dose
ng
per
iu
iu
treat
cell
hr
viral
challeng
moi
furthermor
combin
inhibit
replic
factor
level
compar
exert
ng
iu
furthermor
either
type
use
concentr
ng
ie
iu
respect
ng
combin
otherwis
ineffect
dose
ie
iu
could
highli
potenti
antivir
respons
result
reduct
sarscov
replic
factor
day
infect
figur
efficaci
sarscov
replic
use
alon
combin
consist
observ
studi
addit
vitro
anim
studi
warrant
determin
mechan
protect
whether
type
type
iii
ifn
exert
redund
complementari
synergist
role
host
defens
sarscov
infect
summari
demonstr
human
bronchial
epitheli
cell
capabl
respond
sarscov
infect
tempor
activ
latent
especi
critic
involv
induct
type
ifn
gene
express
subsequ
activ
virusdepend
andor
ifndepend
antivir
signal
pathway
earli
activ
epitheli
cell
would
lead
product
inflammatori
mediat
especi
potenti
exert
detriment
effect
host
immun
respons
part
modul
intrins
function
resid
dc
furthermor
play
indispens
role
induct
optim
express
type
ifn
delay
activ
rel
would
like
postpon
onset
type
ifnmedi
innat
antivir
respons
therebi
greatli
compromis
abil
infect
host
keep
earli
viral
replic
check
despit
delay
express
demonstr
first
time
possess
nonredund
therefor
complementari
activ
sascov
replic
also
identifi
variou
isg
elicit
lung
epitheli
cell
primari
target
cell
sarscov
infect
might
crucial
target
better
understand
initi
innat
adapt
immun
also
futur
develop
innov
therapeut
sar
vero
cell
american
type
cultur
collect
atcc
grown
eagl
minim
essenti
medium
mem
supplement
fetal
calf
serum
fc
design
medium
wherea
human
bronchial
epitheli
cell
atcc
grown
mem
medium
supplement
fc
medium
cell
origin
human
pulmonari
adenocarcinoma
well
character
noncili
human
bronchial
epitheli
cell
mix
phenotyp
use
mani
area
biomed
research
sinc
establish
urbani
strain
sarscov
kindli
provid
us
dr
g
ksiazek
center
diseas
control
prevent
atlanta
ga
use
throughout
studi
origin
stock
sarscov
subject
two
addit
passag
vero
cell
viral
stock
titer
tissu
cultur
infecti
dose
ml
gener
store
prototyp
strain
ig
dhori
viru
dhov
orthomyxoviru
also
use
studi
although
dhov
origin
isol
hyalomma
dromedarii
tick
intranas
infect
mice
tickborn
viru
result
onset
fulmin
uniformli
fatal
ill
mani
clinic
inflammatori
patholog
featur
highli
resembl
observ
mice
infect
highli
pathogen
avian
influenza
viru
ie
origin
stock
dhov
provid
dr
bob
tesh
depart
patholog
utmb
subject
three
addit
passag
vero
cell
use
studi
experi
involv
infecti
dhov
sarscov
conduct
utmb
approv
biosafeti
laboratori
respect
establish
cell
popul
homogen
express
given
intens
perform
standard
limit
dilut
assay
briefli
singlecel
suspens
parent
cell
subject
serial
dilut
medium
follow
cultiv
microtit
plate
cellwel
without
addit
feeder
cell
confluent
subcultur
transfer
plate
expans
cultur
flask
individu
clone
subject
analys
express
suscept
sarscov
infect
immunohistochemistri
ihc
vero
infect
assay
respect
infecti
center
assay
describ
dutta
myrup
use
estim
percentag
sarscovinfect
cell
time
briefli
sarscovinfect
cell
moi
grown
plate
wash
phosphatebuff
salin
pb
indic
time
point
infect
remov
cellfre
virus
infect
cell
harvest
ad
trypsinedta
next
total
cell
recoveri
count
cell
wash
media
final
wash
save
determin
titer
residu
cellfre
virus
standard
plaqu
form
assay
control
fix
number
infect
cell
transfer
confluent
vero
monolay
grown
plate
incub
min
infect
vero
monolay
overlaid
mem
medium
supplement
methylcellulos
fc
three
day
fix
stain
paraformaldehyd
crystal
violet
respect
enumer
plaqu
determin
percentag
infect
cell
individu
time
point
confluent
cell
grown
onto
plate
lyse
standard
buffer
contain
proteinas
inhibitor
remov
cell
debri
centrifug
total
protein
concentr
supernat
measur
use
bca
protein
assay
kit
thermo
fisher
scientif
rockford
il
protein
sampl
mix
trisglycin
sd
sampl
buffer
invitrogen
carlsbad
ca
heatinactiv
fraction
sdspolyacrylamid
gel
electrophoresi
subject
standard
western
blot
transfer
membran
membran
tehn
incub
block
reagent
supplement
ecl
advanc
western
blot
detect
kit
ge
healthcar
piscataway
nj
overnight
follow
addit
incub
overnight
either
goat
antihuman
polyclon
antibodi
mous
cat
abcam
cambridg
wash
tb
blot
membran
allow
react
anoth
hour
hrpconjug
rabbit
antigoat
igg
cat
santa
cruz
biotechnolog
santa
cruz
ca
hrpconjug
goat
antimous
igg
cat
abcam
wash
tb
immunoreact
protein
visual
expos
xray
film
use
ecl
advanc
western
blot
detect
kit
accord
protocol
provid
manufactur
highli
polar
cell
grown
onto
membran
insert
airliquid
phase
fix
mixtur
contain
formaldehyd
glutaraldehyd
trinitrophenol
cacodyl
buffer
ph
least
hr
wash
cacodyl
buffer
cell
fix
buffer
stain
uranyl
acet
maleat
buffer
ph
dehydr
ethanol
embed
polyb
polysci
warrington
pa
embed
membran
cut
slice
stripe
stack
one
side
flat
embed
mold
semithin
section
cut
first
stain
toluidin
blue
examin
choos
area
confluent
monolay
subsequ
ultrathin
section
use
leicareichert
ultracut
ultramicrotom
stain
aqueou
uranyl
acet
lead
citrat
section
examin
philip
electron
microscop
kv
employ
standard
ihc
document
express
sarscov
infect
briefli
sarscovinfect
cultur
grown
plate
wash
phosphatebuff
salin
pb
fix
paraformaldehyd
overnight
rins
pb
block
pb
contain
bovin
serum
albumin
min
cell
incub
h
rabbit
antisarscov
nucleocapsid
protein
np
ie
cat
imgenex
san
diego
ca
wash
pb
cell
stain
dilut
biotinyl
goat
antirabbit
igg
dako
glostrup
denmark
hour
visual
np
achiev
incub
streptavidinalkalin
phosphatas
naphtholfast
red
substrat
dako
dna
microarray
experi
perform
molecular
genom
mg
core
facil
utmb
detail
inform
procedur
use
post
mg
core
facil
websit
genom
scmsutmbedu
character
dynam
spatial
tempor
chang
gene
express
induc
sarscov
dhov
confluent
cell
grown
flask
infect
either
virus
moi
remain
uninfect
control
hr
meet
minim
number
requir
applic
statist
algorithm
perform
studi
triplic
time
point
mock
viral
infect
cultur
yield
total
array
briefli
supernat
harvest
differenti
treat
cultur
hr
pi
subsequ
analys
viral
yield
cytokin
profil
wherea
cell
subject
total
rna
extract
use
kit
follow
protocol
recommend
manufactur
ambion
austin
tx
although
perform
microarraybas
analysi
infect
cell
hr
pi
supernat
parallel
cultur
infect
sarscov
dhov
hr
harvest
profil
inflammatori
respons
purifi
rna
sampl
sent
core
facil
convers
cdna
biotinlabel
hybrid
affymetrix
human
genom
plu
gene
chip
contain
probe
set
identifi
repres
transcript
identifi
wellcharacter
gene
variou
intern
control
affymetrix
santa
clara
ca
mockinfect
cell
compar
cell
infect
either
sarscov
dhov
time
point
comparison
across
differ
array
data
array
normal
robust
multichip
averag
rma
use
spotfir
decisionsit
spotfir
inc
somervil
genesift
vizx
lab
seattl
wa
probe
set
express
valu
level
background
nois
determin
detect
p
valu
disregard
analys
result
analys
indic
rna
sampl
use
data
gener
normal
suffici
high
qualiti
subsequ
analys
data
shown
statist
purpos
array
analyz
separ
group
mock
sarscovinfect
dhovinfect
cell
hr
genesifterbas
normal
follow
pairwis
comparison
averag
group
valu
student
test
benjamini
hochberg
correct
criteria
select
gene
follow
pairwis
comparison
one
group
versu
anoth
eg
mockversussarscov
dhovinfect
cell
hr
expect
least
least
greater
foldchang
observ
two
control
eg
mockinfect
replic
versu
mockinfect
replic
hr
except
made
probe
set
significantli
alter
fold
chang
p
valu
earlier
later
time
point
magnitud
exceed
observ
foldchang
replic
control
least
allow
accur
identif
gene
increas
decreas
express
level
time
fell
stringent
statist
criteria
lower
transcript
level
order
ensur
result
obtain
comparison
viral
infect
cell
specif
infect
probe
set
determin
significantli
differ
hybrid
signal
base
criteria
expect
detect
alter
foldchang
least
greater
magnitud
chang
observ
control
sampl
p
valu
mockinfect
viral
infect
cell
word
gene
express
level
differ
cell
infect
two
differ
virus
consid
irrelev
alter
either
viru
determin
comparison
mockinfect
control
cell
time
point
identifi
independ
andor
redund
gene
express
time
ie
pi
time
point
produc
venn
diagram
venni
websit
http
bioinfogpcnbcsicestoolsvennyindexhtml
function
profil
select
gene
employ
fatigo
http
wwwbabelomicsorg
webbas
function
analysi
tool
determin
whether
given
cluster
gene
enrich
biolog
relev
term
compar
gene
cluster
specif
gene
whose
express
significantli
alter
ie
downregul
gene
infect
cell
time
point
compar
mockinfect
cell
analyz
avail
human
genom
assign
characterist
gene
ontolog
go
term
biolog
process
molecular
function
cluster
gene
addit
transfac
databas
http
wwwgeneregulationcompubdatabaseshtml
employ
explor
transcript
factor
tf
dnabind
site
regul
gene
statist
analysi
use
fisher
exact
test
compar
two
group
gene
extract
go
term
whose
distribut
among
group
significantli
differ
p
valu
obtain
select
go
term
correct
obtain
adjust
p
valu
accord
benjamini
hochberg
correct
adjust
p
valu
chosen
determin
level
statist
signific
biolog
activ
ifn
cultur
supernat
assess
standard
vero
stomat
viru
vsv
base
plaquereduct
assay
describ
langford
colleagu
briefli
supernat
viral
infect
cultur
subject
serial
dilut
vero
monolay
grown
plate
incub
cultur
wash
phosphat
buffer
salin
pb
challeng
plaqueform
unit
pfu
vsv
absorpt
hour
medium
decant
remov
unbound
vsv
follow
addit
cultur
medium
contain
methylcellulos
infect
cultur
incub
hr
subsequ
stain
crystal
violet
enumer
plaqu
recombin
r
contain
specif
activ
iu
intern
unit
per
ng
protein
pbl
biomed
laboratori
piscataway
nj
includ
ifn
bioassay
standard
titer
ifn
test
sampl
express
highest
dilut
give
least
reduct
pfu
vsv
addit
also
titrat
content
supernat
use
commerci
avail
elisa
kit
human
accord
protocol
provid
manufactur
pbl
piscataway
nj
profil
cytokin
respons
infect
cell
employ
bioplex
cytometr
bead
array
biorad
hercul
ca
previous
describ
human
group
group
ii
ie
use
confluent
cell
pretreat
pbl
peprotech
inc
rocki
hill
nj
indic
concentr
either
alon
combin
hr
challeng
sarscov
moi
hr
result
supernat
harvest
assess
yield
infecti
progeni
viru
standard
vero
infect
assay
assess
potenti
inhibit
sarscov
replic
result
rel
cytokin
chemokin
ifn
product
viru
titer
present
mean
standard
deviat
sd
addit
twoway
anova
bonferroni
posthoc
test
use
establish
statist
signific
group
p
comparison
fold
express
mrna
correspond
protein
present
mean
standard
error
mean
sem
correl
coeffici
calcul
spearman
correl
coeffici
analysi
establish
relationship
mrna
correspond
protein
signific
correl
coeffici
also
calcul
f
test
whole
microarray
result
deposit
gene
express
omnibu
geo
http
wwwncbinlmnihgovprojectsgeo
assign
access
number
